0 ns and 75 ns configurations of glycosylated ACE2-FC and its interaction with SARS-CoV-2 binding domains

These are initial and final (75ns) configurations in PDB format
of  glycosylated ACE2-FC fusion proteins which are
promising targets for a COVID-19 therapeutic. Some of them are
in interaction witha fragment of the receptor-binding domain
(RBD) of the Spike Protein S of the SARS-CoV-2 virus. We used
two  glycosylation variants for ACE2-FC, variant 1 is fully
glycosylated with Man8 glycans, variant 2 is fully glycosylated with
GnGnXF3. The Spike RBD is glycosylated with ANaF^6.